Neuropsychological Functioning in Breast Cancer Patients Receiving Adjuvant Aromatase Inhibitor Therapy

被引：0
|
作者：
Weaver, J. R.
Stark, S. M.
Shaverdi, K. T.
Jeter, S.
Zorzi, J.
Skolasky, R. L.
Andrejczuk, M. A.
Sterans, V
Gordon, B.
机构：
来源：
CLINICAL NEUROPSYCHOLOGIST | 2011年 / 25卷 / 05期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：883 / 883
页数：1
相关论文
共 50 条
  • [31] A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy
    Robidoux, A.
    Rich, E.
    Bureau, N. J.
    Mader, S.
    Laperriere, D.
    Bail, M.
    Tremblay, N.
    Patenaude, M.
    Turgeon, J.
    CURRENT ONCOLOGY, 2011, 18 (06) : 285 - 294
  • [32] Progressive relaxation training in patients with breast cancer receiving aromatase inhibitor therapy-randomized controlled trial
    Bahcaci, Umut
    Uysal, Songul Atasavun
    Iyigun, Zeynep Erdogan
    Ordu, Cetin
    Soybir, Gursel Remzi
    Ozmen, Vahit
    PLOS ONE, 2024, 19 (04):
  • [33] Safety of aromatase inhibitor therapy in breast cancer
    Lintermans, Anneleen
    Neven, Patrick
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1201 - 1211
  • [34] Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: A Pilot Study of the Effects of Vaginal Testosterone Therapy
    Dahir, Melissa
    Travers-Gustafson, Dianne
    SEXUAL MEDICINE, 2014, 2 (01): : 8 - 15
  • [35] Bone health in postmenopausal women (PMW) with hormone-sensitive breast cancer (HSBC) receiving adjuvant aromatase inhibitor (AI) therapy
    Kalder, M.
    Hadji, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer
    Kudchadkar, R
    O'Regan, RM
    CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (03) : 145 - 163
  • [37] Adherence to Adjuvant Aromatase Inhibitor Therapy Among Postmenopausal Hispanic/Latino Women With Breast Cancer
    Philipovskiy, Alexander
    Campbell, Aleli
    Heydarian, Rosalinda
    Castillo, Brenda
    Dwivedi, Alok K.
    Mccallum, Richard
    Aguilera, Renato
    Gaur, Sumit
    Nahleh, Zeina
    ANTICANCER RESEARCH, 2020, 40 (02) : 857 - 864
  • [38] Cognitive complaints among Tunisian breast cancer patients receiving adjuvant aromatase-inhibitors
    Ben Abdallah, I.
    Rachdi, H.
    Dhib, D.
    Mejri, N.
    Berrazega, Y.
    El Benna, H.
    Daoud, N.
    Laabidi, S.
    Boussen, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S83 - S83
  • [39] Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study
    Pedersini, Rebecca
    Monteverdi, Sara
    Mazziotti, Gherardo
    Amoroso, Vito
    Roca, Elisa
    Maffezzoni, Filippo
    Vassalli, Lucia
    Rodella, Filippo
    Formenti, Anna Maria
    Frara, Stefano
    Maroldi, Roberto
    Berruti, Alfredo
    Simoncini, Edda
    Giustina, Andrea
    BONE, 2017, 97 : 147 - 152
  • [40] Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients
    Goebel, Andy
    Kuhlmann, Jan D.
    Link, Theresa
    Wimberger, Pauline
    Link-Rachner, Cornelia
    Thiele, Stefanie
    Dell'Endice, Stefania
    Furesi, Giulia
    Breining, Dorit
    Rauner, Martina
    Hofbauer, Lorenz C.
    Rachner, Tilman D.
    JOURNAL OF BONE ONCOLOGY, 2019, 16
12345